CD86 and hepatocellular carcinoma: CD80+, CD83+ or CD86+ cells appeared in the inflammatory zone in the liver tissue of ACH (Fig. 3a–c) or Cir patients, but few positive cells were identified in ACs, HDs or HCC patients.